Metabolic driver of Parkinson’s offers new target for treatment Researchers have identified an important enzyme riding forms of Parkinson’s and have demonstrated how blocking it restores normal function in…
New protein target offers promise for alleviating cognitive decline in Parkinson’s disease A recently published study from researchers at the University of Arizona Health Sciences found that a small protein called PNA5…
Study shows how troriluzole can target early-stage alterations associated with Alzheimer’s In a recent development in Alzheimer’s disease research, scientists at Auburn University have studied a new drug, troriluzole, that may…
